Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation

Transplant Immunology

Volumn 20, Issue 3, 2009, Pages 195-198

  Araujo M B ^a   Leonardi, L S ^b   Leonardi, M I ^b   Boin, I F S F ^b   Magna, L A ^b   Donadi, E A ^c   Kraemer, M H S ^a  

^a Faculty of Medical Science   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allogeneic microchimerism; Immunosuppressive medication; Liver transplantation

Indexed keywords

CYCLOSPORIN A; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROCHIMERISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIZATION;

ADOLESCENT; ADULT; AGED; CHIMERISM; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 57649098384     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.08.009     Document Type: Article

References (29)

1. Starzl T.E., Demetris A.J., Murase N., Ildstad S., Ricordi C., and Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 339 (1992) 1579-1582
2. Starzl T.E., Demetris A.J., Murase N., Thomson A.W., Trucco M., and Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 14 (1993) 326-332
3. Starzl T.E., Demetris A.J., Trucco M., Murase N., Ricordi C., Ildstad S., Ramos H., et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 17 (1993) 1127-1152
4. Ueda M., Hundrieser J., Hisanaga M., Tanaka K., Wonigeit K., Pichlmayr R., et al. Development of microchimerism in pediatric patients after living-related liver transplantation. Clin Transplant 11 (1977) 193-200
5. Benseler V., McCaughan G.W., Schlitt H.J., Bishop G.A., Bowen D.G., and Bertolino P. The liver: a special case in transplantation tolerance. Semin Liver Dis 27 (2007) 194-213
6. Miller A., Dykes D.D., and Polesky H.F. A Simple salting out procedure for extracting DNA human nucleated cells. Nuclei Acids Res 16 (1988) 1215
7. Olerup O., and Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39 (1992) 225
8. Bein G., Gläser R., and Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 39 (1992) 68-73
9. Bilezikçi B., Sahin F., Uyar P., Yillmaz B., Demirhan B., Turan M., et al. Frequency of recipient-derived chimerism and relationship with acute rejection and HLA tissue typing in transplanted liver. Transplant Proc 38 (2006) 598-601
10. Starzl T.E. Chimerism and tolerance in transplantation. Proc Natl Acad Sci 101 (2004) 14607
11. Spriewald B.M., Wassmuth R., Carl H.D., Köckerling F., Reichstetter S., Kleeberger A., et al. Microchimerism after liver transplantation-prevalence and methodological aspects of detection. Transplantation 66 (1998) 77-83
12. Crespo-Leiro M.G., Hermida-Prieto M., Rodrigues J.Á., Muñiz J., Barral S., Paniagua-Martins M.J., et al. Microchimerism after heart transplantation: prevalence, predisposing factors, natural history and prognosis. Transplant Proc 34 (2002) 161-163
13. Araujo M.B., Leonardi L.S., Boin I.F.S.F., Leonardi M.I., and Meirelles L Kraemer M.H.S. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant Proc 36 4 (2004) 953-955
14. Araujo M.B., Leonardi L.S., Boin I.F.S.F., Leonardi M.I., Meirelles L., Kraemer M.H.S., et al. Molecular mechanisms associated with donor-specific microchimerism in peripheral blood of Brazilian patients after liver transplantation. Transplant Proc 38 5 (2006) 1411-1417
15. Shepherd R.W., Turmelle Y., Nadler M., Lowell J.A., Narkewicz M.R., McDiarmid S.V., et al. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 8 (2008) 396-403
16. Starzl T.E., Demetris A.J., Murase N., Ildstad S., Ricordi C., and Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 339 (1992) 1579-1582
17. Sanada O., Sumimoto R., Fukuta Y., Hoshino S., Nishihara M., Kaneda K., et al. Establishment of chimerism in donors by intraportal injection of recipient-type bone marrow cells with concomitant administration of FK 506 before liver transplantation prolongs liver allograft survival in rats. Transplant Proc 30 (1998)
18. Tashiro H., Fukuda Y., Kimura A., Hoshino S., Shintaku S., Ohdan H., et al. Induction of donor-specific hyporeactivity in augmented microchimerism in rat liver transplantation fallowed by donor bone marrow. Transplant Proc 29 (1997) 1196-1197
19. Maria S., and Serdar N. Chimerism and bone marrow based therapies in transplantation. Microsurgery 27 (2007) 510-521
20. Elwood E.T., Larsen C.P., Maurer D.H., Routenberg K.L., Neylan J.F., Welchel J.D., et al. Microchimerism and rejection in clinical transplantation. Lancet 349 (1997) 427-432
21. Li Y., Li X.C., Zheng X.X., Wells A.D., Turka L.A., and Strom T.B. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5 (1999) 1298-1302 after liver transplantation. Liver Transplantation 2008; 14;81-87
22. Li Y., Zheng X.X., Li X.C., Zand M.S., and Strom T.B. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation 66 (1998) 1387-1388
23. Oo Y.H., Dudley T., Nightingale P., Haydon G., and Mutimer D. Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation. Liver Transplant 14 (2008) 81-87
24. Starzl T.E., and Zinkernagel R.M. Transplantation tolerance from a historical perspective. Nat Rev Immunol 1 (2001) 233-239
25. Starzl T.E., and Zinkernagel R.M. Antigen localization and migration in immunity and tolerance. N Engl J Med 339 (1998) 1905-1913
26. Walker L.S., and Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2 (2002) 11-19
27. Leachler R.I., Garden O.A., and Turka L.A. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 3 (2003) 147-158
28. Bettens F., Tiercy J.M., Campanile N., Giostra E., Majno P., Rubbia L., et al. Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity. Liver Transplant 11 (2005) 290-297
29. Ferrand C., Perruche S., Robinet E., Martens A., Tiberghien P., and Saas P. How should chimerism be decoded?. Transplantation 75 (2003) 50S-54S